|
regulation of triglyceride transport
|
GO_1905883 |
[Any process that modulates the frequency, rate or extent of triglyceride transport.] |
|
positive regulation of triglyceride transport
|
GO_1905885 |
[Any process that activates or increases the frequency, rate or extent of triglyceride transport.] |
|
negative regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905888 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905890 |
[Any process that modulates the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
positive regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905889 |
[Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
obsolete positive regulation of cellular response to thapsigargin
|
GO_1905893 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete regulation of cellular response to tunicamycin
|
GO_1905894 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of cellular response to tunicamycin.] |
|
obsolete regulation of cellular response to thapsigargin
|
GO_1905891 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete negative regulation of cellular response to thapsigargin
|
GO_1905892 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete negative regulation of cellular response to tunicamycin
|
GO_1905895 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.] |
|
obsolete positive regulation of cellular response to tunicamycin
|
GO_1905896 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.] |
|
regulation of smooth muscle tissue development
|
GO_1905899 |
[Any process that modulates the frequency, rate or extent of smooth muscle tissue development.] |
|
macromolecule deacylation
|
GO_0098732 |
[The removal of an acyl group, any group or radical of the form RCO- where R is an organic group, from a macromolecule.] |
|
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell
|
GO_0035602 |
[The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.] |
|
tRNA methylthiolation
|
GO_0035600 |
[The addition of a methylthioether group (-SCH3) to a nucleotide in a tRNA molecule.] |
|
peptidyl-cysteine S-nitrosylase activity
|
GO_0035605 |
[Catalysis of the transfer of a nitric oxide (NO) group to a sulphur atom within a cysteine residue of a protein.] |
|
transferase activity, transferring nitrogenous groups
|
GO_0016769 |
[Catalysis of the transfer of a nitrogenous group from one compound (donor) to another (acceptor).] |
|
peptidyl-cysteine S-trans-nitrosylation
|
GO_0035606 |
[Transfer of a nitric oxide (NO) group from one cysteine residue to another.] |
|
peptidyl-cysteine S-nitrosylation
|
GO_0018119 |
[The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.] |
|
fibroblast growth factor receptor signaling pathway involved in hemopoiesis
|
GO_0035603 |
[The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which contributes to hemopoiesis.] |